Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pharma Tech

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

Sep 11, 2026, 1:04 PM

Read Full Article → ERS 2026: BMI, type-2 inflammation, and asthma attack risk

ERS 2026: BMI, type-2 inflammation, and asthma attack risk

Translate article text

Choose a language and wait for the translated text.

At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Meta-Analysis (ORACLE2).

ERS 2026: BMI, type-2 inflammation, and asthma attack risk | PharmaVoice